Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
1.470
+1.470 (0.00%)
Feb 28, 2025, 3:00 PM EST
Silence Therapeutics Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -45.31 | -54.23 | -50.33 | -39.41 | -32.55 | Upgrade
|
| Depreciation & Amortization | 0.59 | 0.62 | 0.6 | 0.43 | 0.5 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | -0 | Upgrade
|
| Stock-Based Compensation | 16.31 | 16.27 | 12.69 | 8.63 | 4.4 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | -4.86 | Upgrade
|
| Other Operating Activities | -6.21 | 3.12 | -0.6 | -1.69 | 3.09 | Upgrade
|
| Change in Accounts Receivable | -0.9 | 0.39 | -0.72 | 27.48 | -29.3 | Upgrade
|
| Change in Accounts Payable | 0.5 | -0.47 | 2.02 | 2.41 | 1.3 | Upgrade
|
| Change in Unearned Revenue | -28.79 | -10.32 | -5.44 | 8.37 | 50.39 | Upgrade
|
| Change in Other Net Operating Assets | -3.83 | -4.84 | -15.26 | 0.59 | -3.73 | Upgrade
|
| Operating Cash Flow | -67.64 | -49.46 | -57.04 | 6.81 | -10.78 | Upgrade
|
| Capital Expenditures | -0.21 | -0.06 | -0.17 | -1.31 | -0.51 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.37 | -0.02 | -0 | Upgrade
|
| Investment in Securities | -21.76 | 19.35 | -19.95 | 10 | 10 | Upgrade
|
| Other Investing Activities | - | - | - | 0.01 | 0.13 | Upgrade
|
| Investing Cash Flow | -21.97 | 19.29 | -20.5 | 8.68 | 9.62 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -0.21 | -0.4 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -0.21 | -0.4 | Upgrade
|
| Issuance of Common Stock | 142.09 | 31.94 | 52.58 | 30.92 | 15.83 | Upgrade
|
| Financing Cash Flow | 142.09 | 31.94 | 52.58 | 30.71 | 15.43 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.06 | 0.75 | -8.12 | -0.11 | -0.34 | Upgrade
|
| Net Cash Flow | 52.54 | 2.52 | -33.08 | 46.09 | 13.93 | Upgrade
|
| Free Cash Flow | -67.85 | -49.52 | -57.22 | 5.5 | -11.29 | Upgrade
|
| Free Cash Flow Margin | -156.85% | -156.49% | -264.22% | 44.26% | -206.00% | Upgrade
|
| Free Cash Flow Per Share | -1.47 | -1.33 | -1.78 | 0.19 | -0.41 | Upgrade
|
| Cash Income Tax Paid | 0.43 | 0.8 | - | - | -3.02 | Upgrade
|
| Levered Free Cash Flow | -25.37 | -24.14 | -25.55 | -4.96 | -34.13 | Upgrade
|
| Unlevered Free Cash Flow | -25.37 | -24.14 | -25.55 | -4.96 | -34.12 | Upgrade
|
| Change in Net Working Capital | 11.07 | 8.21 | 6.28 | -15.95 | 19.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.